Sign In

Misunderstood Nanotech

12 July 2002 10:27
By Tornado Staff

A study, released Thursday by private technology investment group 3i along with the Economist Intelligence Unit and the Institute of Nanotechnology says applications for nanotech are largely misunderstood and investors in the area too shortsighted.

The study includes the opinions of scientists, academics, and industry experts from around the world. It asserts that nanotechnology can contribute to improvements in a variety of areas impacting aspects of people’s lives such as computing, health care, communications, manufacturing, energy and the environment. Nanotechnology is unique in this way, requiring scientists from many different areas to collaborate.

The most successful investments, according to the report, will be in practical applications. Already some of the promising developments improve paints, pigments and coatings for example.

Deep funding will be key to creating successful companies. As evidence of this, strong government funding has helped the US lead in almost every area of nanotech development. Japan and Germany are making strides in the electronic and chemical applications and the UK is a leader in the development of medical and pharmaceutical devices despite modest European government investments.

In order to help the area reach its potential, investors must keep a long-term outlook. ‘Nanotechnology will require sustained investment over a 10 to 20 year period with the support of customers and governments’ says the report.

Startups looking for funding must be crystal-clear about the commercial benefits they can offer. At the same time they must be careful about creating a backlash that nanotech can fix everything.

In order to be successful the report says ‘experts recommend that startups partner with large companies to realize projects they can’t achieve on their own, and bring in people to inject commercial reality into the science.’

Copies of the report: "Size Matters, Building a Successful Nanotechnology Company" are available from 3i on request.

Related stories
VC funding abound for Dutch start-ups
Solar energy back on VCs' agenda?
Deal activity in Europe: London is back on top (after five years)
Interim score for 2014 deal activity: UK back in pole position
A Top VC’s Silicon Valley Update - Matthew Howard, NVP


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Oct 4€16.0MBiopharmaceuticals
Oct 4€1.0MInternet commerce
Oct 4N/ADigital signal processing
Oct 2N/AInternet commerce
Oct 1N/AInternet services
Oct 1N/AMedical devices
Oct 1€12.5MWireless applications

For information on Europe's most extensive database on technology funding click here!


BIO-Europe 2015
November 2 - 4, 2015

November 10 - 11, 2015

Press Releases

Oct 6
versasec triples government security business

Sep 30
BioRegio STERN Management
tübingen-based start-up atriva therapeutics gmbh develops innovativ...

Sep 29
Magic Event
with 1.5 million euros in hand, is looking to attrac...

Sep 29
swarm64 as raises up to eur7.1m from alliance venture, target partn...

Sep 29
Cristal Therapeutics (formerly Cristal Delivery)
cristal therapeutics starts clinical phase i trial with nanomedicin...

About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.